Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2026)

Treace Medical Concepts' Short-term Investments history runs 5 years deep, the most recent figure standing at $42.3 million for Q1 2026.

• Quarterly Short-term Investments fell 32.54% year-over-year to $42.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.3 million (down 32.54% YoY) and the FY2025 annual result came in at $37.7 million, down 41.46% from the prior year.
• Short-term Investments was $42.3 million for Q1 2026 at Treace Medical Concepts, up from $37.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $141.0 million in Q1 2023 and bottomed at $37.7 million in Q4 2025.
• A 5-year average of $80.1 million and a median of $67.5 million in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2023 — Short-term Investments jumped 78.4% — and 2024, when it tumbled 41.64%.
• Treace Medical Concepts' Short-term Investments stood at $61.8 million in 2022, then soared by 78.4% to $110.2 million in 2023, then tumbled by 41.64% to $64.3 million in 2024, then slumped by 41.46% to $37.7 million in 2025, then grew by 12.35% to $42.3 million in 2026.
• Business Quant data shows TMCI's Short-term Investments at $42.3 million in Q1 2026, $37.7 million in Q4 2025, and $49.7 million in Q3 2025.